Bukwang Pharmaceutical Co., Ltd. (KRX: 003000)

Bukwang Pharmaceutical Revenue

Bukwang Pharmaceutical had revenue of 42.60B KRW in the quarter ending September 30, 2024, with 110.33% growth. This brings the company's revenue in the last twelve months to 138.93B, down -14.45% year-over-year. In the year 2023, Bukwang Pharmaceutical had annual revenue of 125.93B, down -34.04%.

• Revenue (ttm): 138.93B
• Revenue Growth: -14.45%
• P/S Ratio: 2.24
• Revenue / Employee: 250.77M
• Employees: 554
• Market Cap: 311.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	125.93B	-64.98B	-34.04%
Dec 31, 2022	190.91B	8.42B	4.61%
Dec 31, 2021	182.49B	12.83B	7.56%
Dec 31, 2020	169.66B	1.47B	0.87%
Dec 31, 2019	168.19B	-26.03B	-13.40%